arrow
M

Masaki Kato

Kansai Medical University
H指数:29
被引数:4,074

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reduced pre-treatment isolated effective coherence between the dorsolateral prefrontal cortex and the subgenual anterior cingulate cortex as a potential predictive marker for remission following repetitive transcranial magnetic stimulation in major depressive disorder

减少预处理后,背外侧前额叶皮层和下扣带回前部皮层之间的有效协同性作为重复经颅磁刺激后重度抑郁症缓解的潜在预测标志物

2026-04-260
OA
A 12-Week, Open-Label, Multicenter Pilot Study to Evaluate the Efficacy and Safety of Lemborexant in Patients with Insomnia Comorbid with Depressive Episodes (SELENADE)

一项为期12周、开放标签、多中心试点研究,旨在评估莱莫雷沙坦在伴有抑郁发作的失眠患者中的有效性和安全性(SELENADE)。

2025-12-040
OAAI
Efficacy and safety of zuranolone in Japanese adults with major depressive disorder: A double-blind, randomized, placebo-controlled, Phase 3 clinical trial

佐诺龙在日本成人重度抑郁症患者中的疗效与安全性:一项双盲、随机、安慰剂对照的III期临床试验

2025-11-011
OAAI
PREDICTORS OF PSYCHIATRIC HOSPITALIZATION AMONG OUTPATIENTS WITH BIPOLAR DISORDER IN THE REAL-WORLD CLINICAL SETTING

真实世界临床环境中双相障碍门诊患者住院的预测因素

2025-02-120
OA
Real-world clinical determinants of alcohol dependence in outpatients with bipolar disorder: a multicenter treatment survey for bipolar disorder in psychiatric outpatient clinics with 2,392 participants
2024-11-070
OAAI
Relapse Following Electroconvulsive Therapy for Schizophrenia: A Systematic Review and Meta-analysis

精神分裂症电休克治疗后复发的系统评价和荟萃分析

2024-10-041
OA
Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: a meta-analysis ( vol 14 , 350 , 2024)
2024-08-310
OAAI
Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: a meta-analysis
2024-07-191
OAAI
Real-world predictors of divorce among outpatients with bipolar disorder: sex differences and clinical implications

双相障碍门诊患者离婚的现实预测因素: 性别差异和临床意义

2023-12-120
OAAI